• Shanghai Bao Pharmaceuticals repurchased 101,700 H shares on July 13 at HKD 19.2–20.24 each; total paid HKD 1.99 million.
• Shares were held as treasury stock, not cancelled; treasury shares rose to 834,900.
• Issued shares excluding treasury fell to 153,492,350; total issued shares stayed at 154,327,250.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shanghai Bao Pharmaceuticals Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260713-12242672), on July 13, 2026, and is solely responsible for the information contained therein.